Irene C. Zaalberg

Irene C. Zaalberg

Auto-generated profile, based on publicly available information

Irene C. Zaalberg

University Medical Center Utrecht

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 April 2022 in Chromosoma
Verified
Journal Article
Open access
PDF file
MIMila Ilić
Mila Ilić
IZIrene C. Zaalberg
Irene C. Zaalberg
JRJonne A. Raaijmakers
Jonne A. Raaijmakers
RMRené H. Medema
René H. Medema
Advances in genome sequencing have revealed a type of extrachromosomal DNA, historically named double minutes (also referred to as ecDNA), to be common in a wide range of cancer types, but not in healthy tissues. These cancer-associated circular DNA molecules contain one or a few genes that are amplified when double minutes accumulate. Double minutes harbor oncogenes or drug resistance genes that contribute to tumor aggressiveness through copy number amplification in combination with favorable epigenetic properties. Unequal distribution of double minutes over daughter cells contributes to intratumoral heterogeneity, thereby increasing tumor adaptability. In this review, we discuss various models delineating the mechanism of generation of double minutes. Furthermore, we highlight how double minutes are maintained, how they evolve, and discuss possible mechanisms driving their elimination.

14 October 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
IZIrene C. Zaalberg
Irene C. Zaalberg
PGPaula Cane Gasull
Paula Cane Gasull
MVMartijn Vromans
Martijn Vromans
MGMeritxell Brunet Guasch
Meritxell Brunet Guasch
NMNatalia Marcekova
Natalia Marcekova
SLSusanne M.A. Lens
Susanne M.A. Lens
Aneuploidy is a hallmark of colorectal cancer, yet the functional consequences of recurrent chromosome gains and losses remain largely unknown. Leveraging advances in human colon organoid culture and chromosome copy number engineering, we here identify the gain of chromosome 7 as an adaptive event following APC loss-of-function mutation. Trisomy 7 confers a cell-intrinsic fitness advantage to APC-mutant colon organoids, while selective removal of the additional chromosome 7 copy from patient-derived colon cancer organoids severely impairs colorectal cancer organoid growth. By comparing transcriptomes of isogenic disomy 7 and trisomy 7 organoid lines, we found that chromosome 7 gain promotes organoid fitness through attenuation of excessive WNT-driven stemness caused by bi-allelic APC mutation. The gain of chromosome 7 thus establishes a just-right WNT signaling state. This effect of chromosome 7 gain is conserved from early adenoma-like APC-mutant organoids to advanced colorectal cancer organoids carrying additional oncogenic driver mutations. Moreover, consistent with our organoid data, gain of chromosome 7 is particularly common in tumors of colorectal cancer patients whose APC genotypes confer relatively high WNT activity. Overall, this work demonstrates that chromosome-specific aneuploidy can act as an adaptive mechanism to optimize, rather than maximize, oncogenic signaling during tumor evolution.